Levamisole Macrocyclic Lactone Anthelmintic Formulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current anthelmintic treatments for ruminants face challenges due to drench resistance, where frequent use accelerates the build-up of resistant worms, and existing formulations struggle to maintain effective control of nematode parasitism in cattle and sheep, particularly with the emergence of resistant strains.
Innovation Solution
The use of levamisole in combination with one or more macrocyclic lactones (MLs) to treat young ruminants at intervals of 40 to 60 days, allowing the immune system to recognize incoming larvae as foreign and mount an immune response, while a long-acting ML formulation provides sustained activity to extend the time between treatments and minimize drench use.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If anthelmintics are used frequently to control worm burden, then effective parasite control is achieved, but drench resistance develops and accelerates
Solution Approach 1:
The treatment is divided into two distinct components: a short-acting anthelmintic (levamisole) that rapidly eliminates adult worms and provides immediate parasite control, and a long-acting macrocyclic lactone that provides sustained protection against reinfection for 40-60 days. This segmentation allows each component to optimize its specific function while together they extend treatment intervals and reduce resistance development.
Solution Approach 2:
The patent implements periodic treatment at extended intervals of 40-60 days rather than frequent continuous treatment. The long-acting macrocyclic lactone maintains therapeutic levels in the animal's system throughout this extended period, providing continuous protection while allowing sufficient time between treatments to prevent the rapid selection and propagation of resistant worm strains.
2Adaptability or versatility
If treatment intervals are extended to minimize drench use, then resistance development is reduced, but effective control of incoming larvae becomes difficult
Solution Approach 1:
The long-acting macrocyclic lactone is administered in advance to establish sustained therapeutic levels in the animal's system before the extended treatment interval begins. This preliminary action ensures that when new infective larvae are encountered during the 40-60 day period, the animal already has adequate drug levels present to effectively control and eliminate them, maintaining reliability throughout the extended interval.
Solution Approach 2:
The macrocyclic lactone formulation is designed to maintain continuous therapeutic action throughout the extended 40-60 day treatment interval. The drug remains active in the animal's system continuously, providing uninterrupted protection against incoming larvae at all stages of the extended period, thereby maintaining effective control without requiring frequent re-treatment.
3Speed
If short-acting anthelmintics are used, then rapid worm elimination is achieved, but treatment frequency must be increased
Solution Approach 1:
The patent merges two anthelmintics with complementary characteristics into a single combination formulation: levamisole, which provides rapid worm elimination through its short-acting mechanism, and a long-acting macrocyclic lactone, which extends protection duration. The combination allows the rapid action of levamisole to quickly reduce existing worm burdens while the macrocyclic lactone simultaneously establishes long-term protection, eliminating the need for frequent repeat treatments.
Data Source
AI summary
A new method of controlling worm burden in ruminants by using two different injectable anthelmintics at or about the same time to increase the time between treatments and to rely on the animal's immune response. One of the anthelmintics is a long acting formulation capable of providing a sustained release of abamectin or other macrocyclic lactone for 2-14 days, to enable the anthelmintic to remove or kill incoming larvae for a sufficiently long period of time to allow the host to recognise the incoming larvae as foreign, and thus allow the ruminant to mount an immune response against these incoming larvae. The other is a short acting anthelmintic such as levamisole designed to substantially eliminate the initial parasite population of adults, juveniles and larvae. They can be combined into a single injectable formulation with a high percentage of levamisole (preferably over 30% of the formulation w/v) together with about 1% w/v of a macrocyclic lactone such as abamectin, dissolved in glycerol formal.